ABSTRACT
Homodimerization of the
-dependent pathway regulating transcription (9) .
Two other families of Wnt receptors have also been reported, the Ryk and Ror proteins (reviewed in references 10 and 11). Little is yet known bout their downstream pathways.
While distinct from each other, Ryks and Rors, unlike the Frizzleds and LRPs, belong to the receptor tyrosine kinase (RTK) superfamily (12) . The Ryks in particular, although not functioning exclusively in the nervous system (13) , have been shown to play important roles there (reviewed in reference 10).
Ryk proteins are highly conserved during metazoan development and have several recognizable domains: an extracellular Wnt inhibitory factor (WIF) domain (14) and a putative juxtamembrane tetrabasic cleavage (TBC) site, both present in the extracellular domain (ECD), a single-pass transmembrane (TM) domain, and an intracellular domain (ICD), which consists of a tyrosine kinase-homologous domain with a putative postsynaptic density protein (PSD95), Drosophila disc large tumor suppressor (Dlg1), and zonula occludens 1 protein (ZO-1) (15) binding domain (PDZ-BD) at the carboxy terminus. Although there is a single Ryk gene in mammals, the Drosophila genome bears three, derailed (drl), , and
Doughnut on 2 (Dnt).
While Ryk was uncovered in mammals by its homology to the tyrosine kinases (16) , the first indications of Ryk's roles in vivo came from studies of the Drosophila drl gene. drl was identified both as a gene controlling axon guidance in the developing embryonic central nervous system (CNS) (17) and as a gene required for wild-type learning and memory in adult flies (18) . DRL is displayed on and controls the trajectories of axons that cross the embryonic ventral midline in the anterior-most of two anterior commissures (AC) present in each hemisegment (19) . The absence of DRL causes these axons to misroute, leading to incompletely separated commissures. Ectopic expression of DRL in posterior commissural (PC) axons, which normally do not express DRL, causes them to cross in the adjacent anterior commissure. DRL thus acts during embryogenesis as a repulsive axon guidance receptor.
A subsequent study demonstrated that the Wnt protein WNT5, previously implicated in embryonic axon guidance (20) , acts as a repulsive ligand for the DRL axons (21) . In wild-type Drosophila embryos, WNT5 is expressed predominantly by PC axons (22) and repulses DRL axons, causing them to cross in the AC. Supporting this model, ectopic expression of WNT5
at the AC ventral midline results in the failure of the AC to form (21, 22) . Both the commissure switching by PC axons ectopically expressing DRL and the disruption of AC formation by ectopic expression of WNT5 provide powerful genetic assays for Drosophila Wnt/Ryk signaling in vivo. Other studies established that the drl adult mutant learning and memory phenotype reflects axon guidance defects in the central complex and mushroom bodies (MBs) (23, 24) , two centers of the brain associated with learning and memory. Furthermore, Drosophila Ryks have been shown to have additional roles both in the CNS and elsewhere.
DRL and DOUGHNUT ON 2 (DNT) act in a subset of muscles to appropriately target them to specific epidermal tendon cells (25, 26) . DRL plays a role in maintaining the wild-type physiology of the larval neuromuscular junction (NMJ) (27) . DRL has also been shown to act as a non-cell-autonomous Wnt-interacting receptor in the MBs (28) and in the antennal lobes of the fly olfactory system (29) . A number of studies of the mammalian Ryk protein indicate that it also plays important roles in several aspects of nervous system development (30) (31) (32) (33) (34) (35) .
Finally, evidence has been provided that injury-induced upregulation of Wnt/Ryk signaling contributes to poor posttrauma axonal regeneration (36-39; reviewed in reference 40), further indicating the need to better understand the relatively poorly characterized interactions of Ryk at the cell surface and to identify members of its downstream pathway.
During embryonic axon guidance in the CNS (19) and in DRL's function at the larval NMJ (27) , the cytoplasmic domain of DRL is required for its function, indicating that DRL acts to transduce the WNT5 signal to as yet unknown cytoplasmic and nuclear targets. DRL however, like the other Ryks, is thought to be catalytically inactive due to a constellation of amino acid substitutions in conserved residues of the kinase domain (16) , raising the question of how it might signal across the membrane. Supporting the hypothesis that DRL is not an active kinase, DRL encoded by a gene bearing a mutation in the codon for an invariant lysine (K371A) in the tyrosine kinase-homologous domain, which is required for catalytic activity, displayed wild-type function in vivo in both dominant gain-of-function and rescue assays in the Drosophila embryonic nervous system and musculature (41) . Furthermore, DRL's purified cytoplasmic domain does not display catalytic phosphor transfer activity (16) and does not detectably bind ATP (F. Shi and M. Lemmon, personal communication Mammalian two-hybrid constructs and procedure.
The Checkmate mammalian two-hybrid system (Promega) was used to assay SRC64B-DRL interactions in SFK-deficient SYF cells (44) (LGC; PromochemATCC), which were transfected using Fugene (Roche). Coding sequences for wild-type and mutant cytoplasmic domains of DRL were cloned in frame with that for the GAL4 DNA-binding domain in the pBind vector, and the full-length wild-type or mutant SRC64B ORFs were cloned in frame with the VP16 activation domain in the pACT vector.
Cell surface biotinylation of DRL.
Cell surface biotinylation experiments were performed on transfected S2 cells using sulfo-Nhydroxysuccinimide (NHS)-LC-biotin (Pierce) at a final concentration of 2 mM for 30 min at room temperature. The reagent was quenched with three wash steps using 1 x phosphate-buffered saline (PBS) containing 100 mM glycine. Double immunoprecipitations were performed as follows.
Cell lysates were first immunoprecipitated with rabbit anti-HA in the highstringency buffer plus protease inhibitors described above. Washed immune complexes were denatured by boiling in SDS, then diluted into Triton X-100-containing buffer, followed by immunoprecipitation with rabbit anti-FLAG antibodies. Proteins were separated by SDS-PAGE and detected on immunoblots with mouse anti-HA, mouse anti-FLAG, and streptavidin-HRP antibodies (Invitrogen).
TOXCAT assays.
TOXCAT assays were performed as previously described (45 was verified by immunoblotting using anti-MBP antisera (New England BioLabs), and the proper membrane insertion of the chimera was verified by a maltose complementation assay described previously (46) . For chloramphenicol acetyltransferase (CAT) assays, MM39 Escherichia coli lysates were prepared as described previously (46) . CAT assays were performed using a CAT enzyme assay system (Promega) according to the manufacturer's instructions.
Fly stocks and immunohistochemistry.
The UAS-DRL-MYC; EG-GAL4 stock was used as previously described (42) 
RESULTS

DRL forms homodimers, and the three Drosophila Ryks form heterodimers.
Receptor dimerization is a mechanism frequently associated with the activation of signaling pathways (47) . To evaluate whether DRL forms homodimers, we coimmunoprecipitated proteins from lysates derived from Drosophila S2 cells transiently cotransfected with plasmids expressing differentially tagged DRL species, DRL-FLAG and DRL-HA. Cell lysates were immunoprecipitated with anti-FLAG, and DRL-HA was detected by anti-HA immunoblotting. DRL-HA was precipitated by anti-FLAG in the presence of DRL-FLAG but not in its absence ( Fig. 1 ). We also examined whether the three Drosophila RYK orthologs, DRL, DRL-2, and DNT, can interact with each other. All pairwise combinations of the three Drosophila Ryk family members formed heterodimeric complexes ( Fig. 1 ). These data indicate that DRL forms homodimeric complexes and that the three Ryk proteins are capable of interacting with each other. DRL homodimers are displayed on the cell surface. To evaluate whether DRL homodimers can be detected at the cell surface, we performed cell Cell lysates were first immunoprecipitated with anti-HA to precipitate DRL-HA-containing complexes; then complexes were washed, disrupted by boiling, and reprecipitated with anti-FLAG to precipitate DRL-FLAG. All samples were immunoblotted (WB) with the appropriate antibodies to detect immunoprecipitation of DRL-HA and potential coimmunoprecipitation of DRL-FLAG and with streptavidin-HRP to detect biotinylated proteins. The expression of DRL wild-type (WT) variants and the efficiency of biotinylation were confirmed by immunoblotting of the whole-cell extract (WCE). (B) The initial anti-HA immunoprecipitates were similarly analyzed, establishing efficient precipitation of the HA-tagged species and coimmunoprecipitation of the FLAG-tagged species (top two panels). Immunoblotting of the doubly immunoprecipitated (anti-HA followed by anti-FLAG) proteins revealed that, while the FLAG-tagged species was precipitated, the HA species was no longer detectable and that the FLAG-tagged species that initially coimmunoprecipitated with the HA-tagged species was detected with streptavidin-HRP (bottom three panels). (C) The lack of biotinylation of simultaneously expressed cytoplasmic GFP confirmed the cell surface specificity of the biotinylation. Thus, we conclude that DRL dimers are present at the cell surface.
WNT5 increases DRL homodimerization in a WIF domain dependent fashion.
We next evaluated how DRL homodimerization is influenced by the presence of its ligand, WNT5. S2 cells express low, but clearly detectable, levels of WNT5 (Fig. 3A) ; therefore, we compared the effects of overexpressing WNT5 with those of a reduction of its expression by preincubation of the cells with double-stranded RNA (dsRNA) targeting the wnt5 transcript (48) . gfp-targeting dsRNA was used as a control for nonspecific effects. The dsRNA treatment was highly effective, as indicated by its ability to suppress the expression of endogenous WNT5 (Fig. 3A) . Reduced expression of WNT5 significantly decreased DRL homodimerization relative to that of the gfp-dsRNA control (Fig. 3B, second The pretreated cells were then transfected in duplicate with DRL-HA and DRL-FLAG, and lysates were immunoprecipitated (IP) with anti-FLAG and immunoblotted (WB) with anti-HA to detect coimmunoprecipitation. Expression of the differentially tagged DRL species was confirmed by WCE immunoblotting. DRL homodimerization was dependent on WNT5 expression, and endogenous levels of WNT5 were sufficient to mediate the dimerization. (C) S2 cells pretreated as above were transfected in duplicate with DRL ΔWIF-HA and DRL ΔWIF-MYC expression constructs. Cell lysates were immunoprecipitated with anti-HA and immunoblotted with anti-MYC to detect coimmunoprecipitation of the differentially tagged species. The expression of both DRL species was confirmed by WCE immunoblotting. DRL ΔWIF formed homodimers that, unlike the wild-type protein, are resistant to the effects of wnt5 knockdown.
Transmembrane domain contributions to DRL homodimerization.
To evaluate which domain of DRL is required for the formation of homodimers, we then performed coimmunoprecipitations from lysates derived from cells pretreated with wnt5-targeting dsRNA and cotransfected with plasmids expressing full-length DRL (DRL-FLAG) and MYC-tagged DRL species lacking either the carboxyterminal PDZ-BD (ΔPDZ-BD), a putative extracellular tetrabasic cleavage site (ΔTBC), the WIF domain (ΔWIF), or the entire intracellular domain (ΔICD). Each of the mutant DRL species retained the ability to interact with full-length DRL (Fig. 4A, bottom panel) . These results indicated that the sequences The sequence of the wild-type DRL TM domain and the locations of small amino acid (Sm)-X-X-X-small amino acid motifs. The wild-type and T245V and G249V mutant TM domains were cloned singly and as a T245V G249V double mutant into the pccKAN vector and transformed into E. coli, and quantitative TOXCAT assays were performed on cell lysates.
Comparison was made to a negative control (pccKAN without a TM domain), a positive control (encoding a fusion bearing the known homodimerizing glycophorin A [Gpa] TM domain), and another negative control (the Gpa TM domain with a mutation [G83I] which abolishes homodimerization). CAT activities were expressed as percentages in comparison to that for the Gpa-TM chimera (100% activity). The data shown are the means from three independent experiments, each performed in triplicate,standard deviations (SD) (,P0.05). The TM domain of DRL displayed robust interaction comparable to that for the Gpa control, and the T245V, but not the G249V, mutation was found to reduce the formation of DRL-TM homodimers (lower panel). (C) To determine that the TOXCAT fusion proteins were the expected size, we prepared lysates of E. coli transformed with the indicated plasmids and analyzed them by anti-MBP immunoblotting. All expression plasmids gave rise to proteins of the anticipated size (top). To confirm the appropriate insertion of the fusion proteins into the periplasmic membrane, transformed E. coli cells were grown on maltose as the sole carbon source; their viability requires the localization of MBP to the periplasmic space. While bacteria transformed with the negative control (pMALc) failed to grow, the others displayed robust growth (bottom). Thus, the TOXCAT test plasmids employed in these studies generated proteins of the anticipated size which were appropriately localized to the periplasmic space.
facilitating ligandindependent DRL homodimerization likely resided in the TM region, which was present in each of these mutant proteins tested. Dimerization through TM region interactions has been reported for a number of receptors (47) and is usually dependent on small structural motifs with a consensus sequence of small amino acid-X-X-X-small amino acid, where X represents any amino acid (49) . We identified two such motifs in the DRL transmembrane domain (Fig. 4B, top Homodimerization mediated by the wild-type DRL TM domain was comparable to that observed with the glycophorin A (Gpa) TM domain, a previously reported homodimerizing sequence (45) . Mutation of the first motif to VLIVG (T245V), but not that of the second motif to VGILA (G249V), resulted in significantly reduced homodimerization (Fig. 4B, bottom panel) .
Thus, we conclude that DRL's ligand-independent homodimerization at the cell surface is likely mediated primarily by the TLIVG motif.
DRL dimerization in the presence of WNT5 or its forced dimerization mediated by the immunoglobulin Fc domain results in increased SRC64B recruitment.
To evaluate the effect of WNT5 binding to DRL on the recruitment of SRC64B by DRL (42),
we determined the levels of SRC64B coimmunoprecipitating with DRL in cells that either overexpressed WNT5 or had reduced expression of WNT5 due to their preincubation with wnt5-targeting dsRNA as described above. Less SRC64B immunoprecipitated with DRL in the presence of wnt5-targeting dsRNA than in the presence of control gfp-targeting dsRNA (Fig. 5) . As was observed in the DRL homodimerization experiments, there was no effect of overexpressing WNT5, presumably due to its already saturating endogenous levels. Thus, WNT5 binding to DRL results in increased recruitment of SRC64B. We reasoned that, if dimerization is involved in DRL receptor activation, increased dimerization should result in increased recruitment of SRC64B. To force DRL dimerization, we constructed a plasmid encoding a fusion protein of DRL with its extracellular domain replaced by the Ig Fc region (Fc-DRL-V5), a previously used dimerization domain (see, for example, references 50 and 51). We established that, as expected, Fc-DRL species form dimers to a larger extent than wild-type DRL, as assayed by coimmunoprecipitation of differentially tagged otherwiseidentical proteins (Fig. 6A , second panel from bottom). Wild-type DRL (DRL-WT-V5) and a TM species lacking the extracellular domain (DRL-ECD-V5) served as controls (Fig. 6B) .
The DRL-encoding plasmids were individually cotransfected into dsRNA-wnt5-treated cells with a tagged SRC64B-encoding plasmid, lysates were prepared and immunoprecipitated with an antibody specific to tagged DRL, and the SRC64B precipitating with the DRL species was detected by antibody specific to tagged SRC64B. We observed increased SRC64B recruitment by Fc-DRL relative to that for both the wild-type and membrane-bound intracellular domain-only proteins (Fig. 6C , lower right panel).
SRC64B's SH2 domain and its catalytic activity are needed for its interaction with DRL.
We then performed mammalian two-hybrid and coimmunoprecipitation assays to identify the domains of SRC64B required for its interaction with DRL. SRC64B has three major domains, the SH3, SH2, and kinase domains (Fig. 7A) . The SH3 and SH2 domains serve to mediate the intraand intermolecular interactions that regulate kinase activity as well as the interaction of SFKs with their substrates (reviewed in reference 52). We generated plasmids encoding SRC64B species lacking either the SH3 or SH2 domain or bearing the kinase activity-destroying K312R point mutation (the equivalent of the mammalian K298R mutation) and tested their abilities to physically interact with DRL. To avoid complications due to DRL homodimerization, we evaluated the interactions of the various SRC64B species with a cytoplasmically localized non-membranetethered wildtype DRL intracellular domain (DRL-ICD-HA). The results from the mammalian two-hybrid assays indicate that SRC64B's SH2 domain, but not its SH3 domain, is required for DRL interaction (Fig. 7B) . Furthermore, they confirm our previous finding (42) that this kinaseinactivating mutation inhibits SRC64B/DRL interaction, indicating that SRC64B kinase activity is required for the recruitment of SRC64B to DRL's cytoplasmic domain. Coimmunoprecipitation experiments confirmed these results (Fig. 7C, second panel from bottom) . Thus, SRC64B
interacts with DRL via its SH2 domain and apparently either must be an active tyrosine kinase or must assume a certain conformation, which is prevented by the K312R mutation, to bind DRL. We also investigated whether kinase-inactive SRC64B could bind to DRL in the presence of active SRC64B e.g., once DRL is phosphorylated by active SRC64B, can the kinase-inactive species bind via its SH2 domain? Cells were cotransfected with a mix of three differently tagged plasmids encoding DRL-ICD-HA, SRC64B-WT-MYC, and SRC64B-kinase-dead-FLAG, and lysates were prepared and immunoprecipitated with anti-HA or anti-FLAG. The SRC64B or DRL species in the complex were detected with tag-specific antibodies on immunoblots. We found that the presence of SRC64B-kinase-dead did not result in a decrease in the amount of active SRC64B that coimmunoprecipitated with DRL-ICD (Fig. 8A) . Conversely, the presence of active SRC64B did not increase the amount of DRL-ICD coimmunoprecipitating with SRC64B-kinasedead (Fig. 8B) . We conclude from this lack of competition between kinase-active and -inactive SRC64B that individual SRC64B molecules binding to DRL must either possess tyrosine kinase activity or adopt a conformation precluded by the K312R mutation.
The PDZ-binding domain of DRL and specific amino acids in its tyrosine kinase-homologous domain are required for its interaction with SRC64B.
We then evaluated the requirement for DRL's cytoplasmic domains in its physical interaction with SRC64B. The two clearly identifiable domains in DRL's intracellular domain are the inactive kinase domain and the carboxy-terminal PDZ-BD (Fig. 9A) . We therefore generated a DRL expression construct bearing two mutations in the tyrosine kinase-homologous domain, K371A and D486A, which mutate conserved amino acids in RTK subdomains II and VII (53), respectively, which are required for catalytic phosphotransfer (52) . We assayed this mutant and another lacking the PDZ-BD for their abilities to interact with SRC64B in mammalian two-hybrid and coimmunoprecipitation experiments. Both mutants failed to interact with SRC64B in either assay ( Fig. 9B and C) , indicating a requirement for the PDZ-BD and for the ability of the DRL cytoplasmic domain to assume a conformation which is precluded by these specific mutations. We then evaluated whether the DRL T245V mutation, which as shown above inhibits ligand-independent DRL TM domainmediated dimerization as determined by TOXCAT assay, affected the ability of DRL to recruit SRC64B. Full-length DRL bearing this mutation displayed reduced complex formation with SRC64B in the presence of endogenous WNT5, relative to the wild-type DRL control, in coimmunoprecipitation assays (Fig. 10) . Thus, impairing TM-mediated dimerization reduces DRL's ability to recruit SRC64B. To ascertain the requirement for DRL's intracellular domains, we performed mammalian two-hybrid assays. The indicated fusion protein constructs were transiently transfected into SYF (SFK-deficient) cells in triplicate, and luciferase activity was measured 48 h posttransfection and plotted, normalized to an internal control. DRL, but not the double kinase or ΔPDZ-BD mutant, interacts with SRC64B. (C) To confirm the mammalian two-hybrid results, we performed coimmunoprecipitation experiments. S2 cells were transiently transfected with the indicated expression constructs, and lysates were immunoprecipitated (IP) with antibody specific to SRC64B (anti-FLAG) and immunoblotted (WB) with the reciprocal antibody (anti-HA) to detect coimmunoprecipitation of the DRL species. The expression of DRL ICD variants and SRC64B was confirmed by immunoblotting the whole-cell extract (WCE). The DRL double kinase domain and ΔPDZ-BD mutants display significantly less interaction with SRC64B than the wild-type control.
Fig 10
Reduced recruitment of SRC64B by DRL bearing the TM T245V mutation. S2 cells were transfected with the indicated plasmids, and lysates were prepared and immunoprecipitated with anti-FLAG (SRC64B). Expression of the DRL and SRC64B species was confirmed by anti-FLAG and antiMYC immunoblots of whole-cell lysates (WCE), and the efficiency of immunoprecipitation was confirmed with anti-FLAG. Significantly less DRL T245V immunoprecipitated with SRC64B, as detected by anti-MYC immunoblots of the anti-FLAG immunoprecipitates, than the wild-type DRL control.
In vivo requirements for DRL's WIF domain, tetrabasic cleavage site, and cytoplasmic domain in an axon commissure switching assay.
To evaluate the roles of the various extra-and intracellular domains of DRL, we generated UAS-MYC-tagged transgenes of mutant DRL ORFs (ΔWIF, ΔTBC, ΔICD, and ΔPDZ-BD)
by random P-element insertion and generated a collection of roughly expression-matched inserts by performing quantitative anti-MYC immunoblotting of dissected third-instar larval central nervous systems expressing the UAS transgene under the control of a panneural driver (data not shown). The transgenes were then evaluated in a previously described (19) assay for DRL function, specifically as described above, for their ability to cause commissure switching of a subset of EG-GAL4 + neurons which normally cross the ventral nerve cord midline in the more posterior of the two commissures found in each hemisegment. We performed this assay in a genetic background sensitized by the presence of one copy of wild-type UAS-DRL, which is not sufficient to cause commissure switching by itself (42) (Fig.   11 ). Quantitation of the switching events indicates that DRL's WIF, TBC, and ICD domains are required to force commissure switching, while the Δ-PDZ-BD mutation decreases DRL's activity in this assay by approximately one-third (Fig. 11) . Unexpectedly, the mutation affecting TM homodimerization in the TOXCAT assay, DRL T245V, had no apparent effect (discussed below). Thus, we conclude that DRL function during embryonic CNS development requires The specific sequences mediating the likely TM-dependent homodimerization of other Ryks have not been determined, but we note that DRL-2 has six such motifs, DNT has three, and human Ryk bears two in their TM domains (data not shown).
We observed that, although the protein bearing the mutation (T245V) that reduced DRL TM activity in the TOXCAT assay displayed reduced SRC64B recruitment, DRL T245V enhanced Both mammalian two-hybrid and coimmunoprecipitation experiments confirmed our earlier report (42) that SRC64B's kinase activity is required for its interaction with DRL. Here, we investigated whether DRL phosphorylated by active SRC64B could bind to the kinase-dead SRC64B. We found that, even in the presence of active SRC64B, the kinase-dead species interacts very weakly with DRL and does not effectively compete active SRC64B out of its complex with DRL. Although we cannot rule out the possibility that, once active SRC64B
phosphorylates DRL, it binds sufficiently tightly that exchange with the kinase-dead species is infrequent, it seems probable that individual SRC64B molecules must possess kinase activity to interact with DRL. Alternatively, the K312R mutation somehow precludes SRC64B from attaining a particular conformation required for its interaction with DRL. We conclude based on these data that SRC64B must be able to autophosphorylate or phosphorylate DRL to effect its binding to DRL.
We observed that mutations in DRL's tyrosine kinase-homologous domain interfered with its ability to interact with SRC64B despite DRL's inability to bind to ATP and catalyze phosphotransfer. Although formal proof will require determination of the structure of DRL's intracellular domain in a complex with SRC64B, we speculate that these data indicate that DRL's intracellular domain must adopt a particular conformation in order to interact with and regulate the localization or activity of SRC64B. Such allosteric interactions between pseudokinases and their signaling partners have been the subject of recent interest (60) (61) (62) . One such example is the STRAD pseudokinase, which, in combination with scaffolding protein MO25, regulates the LKB1 tumor suppressor protein kinase (63, 64) . Activation of LKB1 requires that STRAD adopt a "closed" conformation, one associated with active protein kinases. It has thus become clear that at least some pseudokinases do not act merely as passive scaffolds but must assume specific conformations in order to bind or activate downstream pathway members. DRL's non-cell-autonomous role in the MBs indicates that its extracellular Wnt-binding domain is shed from MB-extrinsic neurons to play a role in MB axon guidance (28) . The role of the TBC motif in signal transduction during embryonic axon guidance, where DRL transduces a signal via its cytoplasmic domain, is presently less obvious. Possibly, it is involved in the proteolytic processing of DRL prior to intramembrane cleavage to release its intracellular domain for transit to the nucleus as has been reported for mammalian Ryk (33) . WNT5 signaling through DRL, therefore, likely involves a complex set of events, including dimerization, proteolytic cleavage at the TBC site, and the interaction of DRL's cytoplasmic domain, via both its tyrosine kinasehomologous domain and PDZ-BD, with SRC64B and other proteins yet to be identified.
